Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors

Biological Psychiatry

Volumn 72, Issue 11, 2012, Pages 898-906

  Kometer, Michael ^a   Schmidt, André ^a   Bachmann, Rosilla ^a   Studerus, Erich ^a   Seifritz, Erich ^a   Vollenweider, Franz X ^a  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

Author keywords

Affect; anxiety; depression; emotion; P300; serotonin

Indexed keywords

KETANSERIN; PLACEBO; PSILOCYBINE;

ADULT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; EMOTION; EVENT RELATED POTENTIAL; FACIAL EXPRESSION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SELF REPORT;

ADULT; AFFECT; CEREBRAL CORTEX; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EMOTIONS; EVOKED POTENTIALS; FEMALE; GOALS; HALLUCINOGENS; HUMANS; KETANSERIN; MALE; NEUROPSYCHOLOGICAL TESTS; PSILOCYBINE; RECEPTORS, SEROTONIN; RECOGNITION (PSYCHOLOGY); SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS;

EID: 84868197215     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.04.005     Document Type: Article

References (74)

1. J. Joormann, I.H. Gotlib Is this happiness I see? Biases in the identification of emotional facial expressions in depression and social phobia J Abnorm Psychol 115 2006 705 714
2. F.C. Murphy, B.J. Sahakian, J.S. Rubinsztein, A. Michael, R.D. Rogers, T.W. Robbins, E.S. Paykel Emotional bias and inhibitory control processes in mania and depression Psychol Med 29 1999 1307 1321
3. K. Erickson, W.C. Drevets, L. Clark, D.M. Cannon, E.E. Bain, C.A. Zarate Mood-congruent bias in affective go/no-go performance of unmedicated patients with major depressive disorder Am J Psychiatry 162 2005 2171 2173
4. R. Elliott, R. Zahn, J.F.W. Deakin, I.M. Anderson Affective cognition and its disruption in mood disorders Neuropsychopharmacology 36 2011 153 182
5. T. Sharp, P.J. Cowen 5-HT and depression: Is the glass half-full? Curr Opin Pharmacol 11 2011 45 51
6. L.N. Yatham, P.F. Liddle, J. Dennie, I.S. Shiah, M.J. Adam, C.J. Lane Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: A positron emission tomography study with fluorine-18-labeled setoperone Arch Gen Psychiatry 56 1999 705 711
7. P.R. Albert, B.L. François Modifying 5-HT1A receptor gene expression as a new target for antidepressant therapy Front Neurosci 4 2010 35
8. J.H. Meyer, S. McMain, S.H. Kennedy, L. Korman, G.M. Brown, J.N. DaSilva Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm Am J Psychiatry 160 2003 90 99
9. J. Meyer Neuroimaging markers of cellular function in major depressive disorder: Implications for therapeutics, personalized medicine, and prevention Clin Pharmacol Ther 91 2012 201 214
10. Z. Bhagwagar, R. Hinz, M. Taylor, S. Fancy, P. Cowen, P. Grasby Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: A positron emission study with [(11)C]MDL 100,907 Am J Psychiatry 163 2006 1580 1587
11. G.M. Sullivan, R.T. Ogden, M.A. Oquendo, J.S. Kumar, N. Simpson, Y.Y. Huang Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression Biol Psychiatry 66 2009 223 230
12. L.N. Yatham, P.F. Liddle, J. Erez, M. Kauer-Sant'Anna, R.W. Lam, M. Imperial Brain serotonin-2 receptors in acute mania Br J Psychiatry 196 2010 47 51
13. E. Akimova, R. Lanzenberger, S. Kasper The serotonin-1A receptor in anxiety disorders Biol Psychiatry 66 2009 627 635
14. D. Perani, V. Garibotto, A. Gorini, R.M. Moresco, M. Henin, A. Panzacchi In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder Neuroimage 42 2008 306 314
15. M.C. Scorza, M. Reyes-Parada, R. Silveira, H. Viola, J.H. Medina, M.B. Viana Behavioral effects of the putative anxiolytic (+/-)-1-(2,5-dimethoxy-4- ethylthiophenyl)-2-aminopropane (ALEPH-2) in rats and mice Pharmacol Biochem Behav 54 1996 355 361
16. B.A. Nic Dhonnchadha, M. Bourin, M. Hascoët Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety Behav Brain Res 140 2003 203 214
17. F. Massé, B.A. Nic Dhonnchadha, M. Hascoët, M. Bourin Anxiolytic-like effect of 5-HT(2) ligands and benzodiazepines co-administration: Comparison of two animal models of anxiety (the four-plate test and the elevated plus maze) Behav Brain Res 177 2007 214 226
18. V. Nunes-de-Souza, R.L. Nunes-de-Souza, R.J. Rodgers, A. Canto-de-Souza 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice Behav Brain Res 187 2008 72 79
19. K.S. Gomes, R.L. Nunes-De-Souza Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice Prog Neuropsychopharmacol Biol Psychiatry 33 2009 1261 1269
20. A. Donatti, C. Leite-Panissi GABAergic antagonist blocks the reduction of tonic immobility behavior induced by activation of 5-HT2 receptors in the basolateral nucleus of the amygdala in guinea pigs Brain Res Bull 79 2009 358 364
21. E.S. da Silva, S.C. Poltronieri, J.O. Nascimento, H. Zangrossi, M.B. Viana Facilitation of 5-HT(2A/2C)-mediated neurotransmission in the ventromedial hypothalamic nucleus decreases anxiety in the elevated T-maze Behav Brain Res 216 2011 692 698
22. F.X. Vollenweider, M.F. Vollenweider-Scherpenhuyzen, A. Bäbler, H. Vogel, D. Hell Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action Neuroreport 9 1998 3897 3902
23. E. Studerus, M. Kometer, F. Hasler, F.X. Vollenweider Acute, subacute and long-term subjective effects of psilocybin in healthy humans: A pooled analysis of experimental studies J Psychopharmacol 25 2011 1434 1452
24. F.X. Vollenweider, M. Kometer The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders Nat Rev Neurosci 11 2010 642 651
25. M. Kometer, B.R. Cahn, D. Andel, O.L. Carter, F.X. Vollenweider The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations Biol Psychiatry 69 2011 399 406
26. J.B. Blair, D. Kurrasch-Orbaugh, D. Marona-Lewicka, M.G. Cumbay, V.J. Watts, E.L. Barker, D.E. Nichols Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines J Med Chem 43 2000 4701 4710
27. D.E. Nichols Hallucinogens Pharmacol Ther 101 2004 131 181
28. C.S. Grob, A.L. Danforth, G.S. Chopra, M. Hagerty, C.R. McKay, A.L. Halberstadt, G.R. Greer Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer Arch Gen Psychiatry 68 2011 71 78
29. T.A. Victor, M.L. Furey, S.J. Fromm, A. Ohman, W.C. Drevets Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder Arch Gen Psychiatry 67 2010 1128 1138
30. G. Hayward, G.M. Goodwin, P.J. Cowen, C.J. Harmer Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms Biol Psychiatry 57 2005 517 524
31. Z. Bhagwagar, P.J. Cowen, G.M. Goodwin, C.J. Harmer Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression Am J Psychiatry 161 2004 166 168
32. C.J. Harmer, Z. Bhagwagar, D.I. Perrett, B.A. Völlm, P.J. Cowen, G.M. Goodwin Acute SSRI administration affects the processing of social cues in healthy volunteers Neuropsychopharmacology 28 2003 148 152
33. G. Bedi, D. Hyman, H. de Wit Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others Biol Psychiatry 68 2010 1134 1140
34. K.P. Schulz, S.M. Clerkin, J.M. Halperin, J.H. Newcorn, C.Y. Tang, J. Fan Dissociable neural effects of stimulus valence and preceding context during the inhibition of responses to emotional faces Hum Brain Mapp 30 2009 2821 2833
35. O.J. Robinson, B.J. Sahakian A double dissociation in the roles of serotonin and mood in healthy subjects Biol Psychiatry 65 2009 89 92
36. F.C. Murphy, K.A. Smith, P.J. Cowen, T.W. Robbins, B.J. Sahakian The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers Psychopharmacology (Berl) 163 2002 42 53
37. A. Feder, J. Skipper, J.R. Blair, K. Buchholz, S.J. Mathew, M. Schwarz Tryptophan depletion and emotional processing in healthy volunteers at high risk for depression Biol Psychiatry 69 2011 804 807
38. D. Sheehan, Y. Lecrubier, K. Sheehan, P. Amorim, J. Janavs, E. Weiller The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry 59 1998 22 33
39. H.-U. Wittchen, H. Pfister DIA-X-Interviews: Manual für Screening-Verfahren und Interview 1997 Swets & Zeitlinger Frankfurt, Germany
40. L. Derogatis SCL-90-R: Symptom Checklist-90-R Administration, Scoring and Procedures Manual 1994 National Computer Systems Inc Minneapolis
41. O. Carter, D. Burr, J. Pettigrew, G. Wallis, F. Hasler, F. Vollenweider Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors J Cogn Neurosci 17 2005 1497 1508
42. A. Dittrich The standardized psychometric assessment of altered states of consciousness (ASCs) in humans Pharmacopsychiatry 31 1998 80 84
43. E. Studerus, A. Gamma, F.X. Vollenweider Psychometric evaluation of the altered states of consciousness rating scale (OAV) PLoS One 5 2010 e12412
44. D. Watson, L.A. Clark, A. Tellegen Development and validation of brief measures of positive and negative affect: The PANAS scales J Pers Soc Psychol 54 1988 1063 1070
45. H.W. Krohne, B. Egloff, C.-W. Kohlmann, A. Tausch Untersuchungen mit einer deutschen Form der Positive and Negative Affect Schedule (PANAS) Diagnostica 42 1996 139 156
46. C.D. Spielberger, R.L. Gorsuch, R.E. Lushene Manual for the State and Trait Anxiety Inventory 1983 Consulting Psychologist Press Palo Alto, CA
47. S. Baron-Cohen, S. Wheelwright, J. Hill, Y. Raste, I. Plumb The "Reading the Mind in the Eyes" Test revised version: A study with normal adults, and adults with Asperger syndrome or high-functioning autism J Child Psychol Psychiatry 42 2001 241 251
48. K. Harkness, M. Sabbagh, J. Jacobson, N. Chowdrey, T. Chen Enhanced accuracy of mental state decoding in dysphoric college students Cogn Emot 19 2005 999 1025
49. S. Frühholz, A. Jellinghaus, M. Herrmann Time course of implicit processing and explicit processing of emotional faces and emotional words Biol Psychol 87 2011 265 274
50. M.L. Võ, M. Conrad, L. Kuchinke, K. Urton, M.J. Hofmann, A.M. Jacobs The Berlin Affective Word List Reloaded (BAWL-R) Behav Res Methods 41 2009 534 538
51. F. Perrin, J. Pernier, O. Bertrand, J.F. Echallier Spherical splines for scalp potential and current density mapping Electroencephalogr Clin Neurophysiol 72 1989 184 187
52. A.J. Bell, T.J. Sejnowski An information-maximization approach to blind separation and blind deconvolution Neural Comput 7 1995 1129 1159
53. T.W. Lee, M. Girolami, T.J. Sejnowski Independent component analysis using an extended infomax algorithm for mixed subgaussian and supergaussian sources Neural Comput 11 1999 417 441
54. J.P. Roiser, J. Levy, S.J. Fromm, A.C. Nugent, S.L. Talagala, G. Hasler The effects of tryptophan depletion on neural responses to emotional words in remitted depression Biol Psychiatry 66 2009 441 450
55. C.J. Harmer, J. Heinzen, U. O'Sullivan, R.A. Ayres, P.J. Cowen Dissociable effects of acute antidepressant drug administration on subjective and emotional processing measures in healthy volunteers Psychopharmacology (Berl) 199 2008 495 502
56. J.H. Krystal, J.P. Seibyl, L.H. Price, S.W. Woods, G.R. Heninger, G.K. Aghajanian, D.S. Charney m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients Evidence implicating serotonergic systems in the positive symptoms of schizophrenia Arch Gen Psychiatry 50 1993 624 635
57. A.R. Hariri, A. Holmes Genetics of emotional regulation: The role of the serotonin transporter in neural function Trends Cogn Sci 10 2006 182 191
58. N.S. Burghardt, G.M. Sullivan, B.S. McEwen, J.M. Gorman, J.E. LeDoux The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: A comparison with tianeptine Biol Psychiatry 55 2004 1171 1178
59. R.A. Lyon, R.A. Glennon, M. Titeler 3,4-Methylenedioxymethamphetamine (MDMA): Stereoselective interactions at brain 5-HT1 and 5-HT2 receptors Psychopharmacology (Berl) 88 1986 525 526
60. M. Yamauchi, T. Miyara, T. Matsushima, T. Imanishi Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors Brain Res 1067 2006 164 169
61. J.H. Meyer, S. Kapur, B. Eisfeld, G.M. Brown, S. Houle, J. DaSilva The effect of paroxetine on 5-HT(2A) receptors in depression: An [(18)F]setoperone PET imaging study Am J Psychiatry 158 2001 78 85
62. K.P. Schulz, J. Fan, O. Magidina, D.J. Marks, B. Hahn, J.M. Halperin Does the emotional go/no-go task really measure behavioral inhibition? Convergence with measures on a non-emotional analog Arch Clin Neuropsychol 22 2007 151 160
63. S.J. Thomas, C.J. Gonsalvez, S.J. Johnstone Sequence effects in the Go/NoGo task: Inhibition and facilitation Int J Psychophysiol 74 2009 209 219
64. S.L. Rossell, A.C. Nobre Semantic priming of different affective categories Emotion 4 2004 354 363
65. K. Sass, U. Habel, O. Sachs, W. Huber, S. Gauggel, T. Kircher The influence of emotional associations on the neural correlates of semantic priming Hum Brain Mapp 33 2012 676 694
66. J. Joormann Attentional bias in dysphoria: The role of inhibitory processes Cogn Emot 18 2004 125 147
67. E. Goeleven, R. De Raedt, S. Baert, E.H. Koster Deficient inhibition of emotional information in depression J Affect Disord 93 2006 149 157
68. C.R. Markus, R. De Raedt Differential effects of 5-HTTLPR genotypes on inhibition of negative emotional information following acute stress exposure and tryptophan challenge Neuropsychopharmacology 36 2011 819 826
69. P.H. Chiu, A.J. Holmes, D.A. Pizzagalli Dissociable recruitment of rostral anterior cingulate and inferior frontal cortex in emotional response inhibition Neuroimage 42 2008 988 997
70. J.W. Krompinger, R.F. Simons Electrophysiological indicators of emotion processing biases in depressed undergraduates Biol Psychol 81 2009 153 163
71. J. Polich Updating p300: An integrative theory of P3a and P3b Clin Neurophysiol 118 2007 2128 2148
72. E. Gouzoulis-Mayfrank, B. Thelen, S. Maier, K. Heekeren, K. Kovar, H. Sass, M. Spitzer Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans Neuropsychobiology 45 2002 205 212
73. F. Vollenweider, P. Csomor, B. Knappe, M. Geyer, B. Quednow The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval Neuropsychopharmacology 32 2007 1876 1887
74. E. Nyman, J. Miettunen, N. Freimer, M. Joukamaa, P. Maki, J. Ekelund Impact of temperament on depression and anxiety symptoms and depressive disorder in a population-based birth cohort J Affect Disord 131 2011 393 397